Late onset membranous nephropathy complicating donor lymphocyte infusion for leukaemia relapse after allogeneic stem cell transplantation [1]

American Journal of Hematology

Volumn 82, Issue 4, 2007, Pages 327-328

  Lam, M F ^a   Au, W Y ^a   Tse, K C ^a   Chan, T M ^a   Chan, G S W ^a   Chan, K W ^a   Lai, K M ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMATINIB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; CASE REPORT; DONOR LYMPHOCYTE INFUSION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKEMIA; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL;

ADULT; GLOMERULONEPHRITIS, MEMBRANOUS; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LYMPHOCYTE TRANSFUSION; MALE; TIME FACTORS; TRANSPLANTATION CHIMERA;

EID: 34147124211     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20788     Document Type: Letter

References (5)

1. Cruz DN, Perazella MA, Mahnensmith RL. Bone marrow transplant nephropathy: A case report and review of literature. J Am Soc Nephrol 1997;8:166-173.
2. Sato N, Kishi K, Yagisawa K, et al. Nephrotic syndrome in a bone marrow transplant recipient with chronic graft-versus-host disease. Bone Marrow Transplant 1995;16:303-305.
3. Ma SY, Au WY. Lie AK, et al. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004;34:57-61.
4. Miyazaki Y, Mori Y, Kishimoto N, et al. Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation. Int J Hematol 2003;78:262-265.
5. Chien YH, Lin KH, Lee TY, Lu MY, Tsau YK. Nephrotic syndrome in a bone marrow transplant recipient without chronic graft-versus-host disease. J Formos Med Assoc 2000;99:503-506.